Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
Argus Health
Harvard Business School
Moodys
US Department of Justice

Generated: March 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Napabucasin

« Back to Dashboard

US Patents for Napabucasin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Napabucasin ➤ Try a Free Trial Anticancer agent Kyoto Pharmaceutical Industries, Ltd. (Kyoto, JP) Sumitomo Dainippon Pharma Co., Ltd. (Osaka, JP) ➤ Try a Free Trial
Napabucasin ➤ Try a Free Trial Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents The University of North Carolina at Chapel Hill (Chapel Hill, NC) ➤ Try a Free Trial
Napabucasin ➤ Try a Free Trial Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents University of North Carolina at Chapel Hill (Chapel Hill, NC) ➤ Try a Free Trial
Napabucasin ➤ Try a Free Trial Anti-drug resistant strain agents and antichlamydia agents Japan Science and Technology Corporation (Saitama, JP) ➤ Try a Free Trial
Napabucasin ➤ Try a Free Trial Stat3 pathway inhibitors and cancer stem cell inhibitors Boston Biomedical, Inc. (Cambridge, MA) ➤ Try a Free Trial
Napabucasin ➤ Try a Free Trial Compounds and compositions for targeting cancer stem cells Boston Biomedical, Inc. (Cambridge, MA) ➤ Try a Free Trial
Napabucasin ➤ Try a Free Trial Esters of 4, 9-dihydroxy-naphtho [2, 3-b] furans for disease therapies Zhoushan Haizhongzhou Xinsheng Pharmaceuticals Co., Ltd. (Zhoushan, Zhejiang, CN) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Napabucasin

Drugname Country Document Number Estimated Expiration Related US Patent
Napabucasin Australia 2015272560 2034-06-09 ➤ Try a Free Trial
Napabucasin Canada 2951627 2034-06-09 ➤ Try a Free Trial
Napabucasin European Patent Office 3153508 2034-06-09 ➤ Try a Free Trial
Napabucasin Japan WO2015190489 2034-06-09 ➤ Try a Free Trial
Napabucasin World Intellectual Property Organization (WIPO) 2015190489 2034-06-09 ➤ Try a Free Trial
Napabucasin Australia 4548899 2018-06-05 ➤ Try a Free Trial
Napabucasin China 1150197 2018-06-05 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
Covington
US Army
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.